Henan Lingrui Pharmaceutical Co has a quick ratio of 0.99. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Henan Lingrui Pharmaceutical Co's Quick Ratio or its related term are showing as below:
SHSE:600285'
s Quick Ratio Range Over the Past 10 Years
Min: 0.81 Med: 1.25 Max: 1.54
Current: 0.99
During the past 13 years, Henan Lingrui Pharmaceutical Co's highest Quick Ratio was 1.54. The lowest was 0.81. And the median was 1.25.
SHSE:600285's Quick Ratio is ranked worse than 66.17% of 999
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs SHSE:600285: 0.99
Henan Lingrui Pharmaceutical Co (SHSE:600285) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Henan Lingrui Pharmaceutical Co Quick Ratio Related Terms
Henan Lingrui Pharmaceutical Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henan Lingrui Pharmaceutical Co Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Quick Ratio falls into.
Henan Lingrui Pharmaceutical Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a Quick Ratio of 0.99 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. This is 21% below median its historical median of 1.25. Over the past decade, Henan Lingrui Pharmaceutical Co's Quick Ratio has ranged from 0.81 to 1.54. According to the industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #661 out of 999 companies in the Drug Manufacturers industry, placing it in the top 66.2%.
Is Henan Lingrui Pharmaceutical Co's Quick Ratio too high?
Henan Lingrui Pharmaceutical Co's current Quick Ratio of 0.99 is 21% below median its 10-year median of 1.25. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 1.54. The Drug Manufacturers industry median Quick Ratio is 1.45. Henan Lingrui Pharmaceutical Co's value of 0.99 is 31.7% below this industry median. Based on the distribution chart, Henan Lingrui Pharmaceutical Co ranks #661 out of 999 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #661 out of 999 companies for Quick Ratio. This places Henan Lingrui Pharmaceutical Co in the lower half of its industry. The industry median Quick Ratio is 1.45. Henan Lingrui Pharmaceutical Co's value of 0.99 is 31.7% below this benchmark. Historically, Henan Lingrui Pharmaceutical Co's own Quick Ratio has ranged from 0.81 to 1.54 over the past decade. While the company's 10-year median is 1.25 vs. the industry median of 1.45, Henan Lingrui Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henan Lingrui Pharmaceutical Co's current Quick Ratio of 0.99 is 31.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henan Lingrui Pharmaceutical Co's current Quick Ratio is 0.99, which is 21% below median its own 10-year median of 1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.39, compared to a current price of ¥22.54 — trading 7.6% below its estimated fair value. The current Quick Ratio is 0.99, which is 21% below median its 10-year median of 1.25 and 31.7% below the Drug Manufacturers industry median of 1.45. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current Quick Ratio is 0.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥22.54 is trading 7.6% below its estimated GF Value™ of ¥24.39.
GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600285:
Quick Ratio: 0.99 (21% below median its 10-year median of 1.25)
GF Value™: ¥24.39 vs. price of ¥22.54 (7.6% below fair value)
Industry Position: 31.7% below the Drug Manufacturers median (#661 of 999)
No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henan Lingrui Pharmaceutical Co Business Description
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
97GF Score
Get the complete analysis for SHSE:600285
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600285 has been successfully added to your 
